American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

Option Therapeutics Inc. (OPTN)

$9.60 +0.00% OPTN · 15-min delayed

CARSON CITY, Nevada
Public · OPTN

OPTNListed

About Option Therapeutics Inc.

Option Therapeutics Inc. is an American company based in CARSON CITY, Nevada.

This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.

Company facts

Type: Public · OPTN
Headquarters: CARSON CITY, Nevada
Industry: Pharmaceuticals

Registry IDs

Ticker: OPTN
SEC CIK: 2070577
EIN: 334884057
SIC: 2834 Pharmaceutical Preparations

Embed this company’s badge

Show Option Therapeutics Inc.’s American-company profile badge on a website — copy this HTML:

<a href="https://americancompanies.com/company/option-therapeutics-inc/"><img src="https://americancompanies.com/badge/option-therapeutics-inc.svg" alt="Option Therapeutics Inc. — American company profile on americancompanies.com" width="220"></a>

Is this your company?

This profile is unclaimed — any authorized owner can claim it, control the page, and earn the Verified badge.

Claim this profile

Track American companies

Create a free account to follow Option Therapeutics Inc. and get an email when it moves sharply — real market data, 15-minute delayed.

Create free account

Listed: OPTN

$9.60 +0.00%

15-minute delayed · data by Polygon.io

EPS (diluted): $-2.12
Open: —
Day range: –
Prev close: —
Volume: —

Option Therapeutics Inc. (OPTN) Stock Price

Revenue grew 59% from FY2020 to FY2024.
Gross margin of 90.8%, net margin -27.5%.
Trading near its 52-week high.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

No reviews yet. Be the first to review Option Therapeutics Inc..

Write a review

Newsroom

News about Option Therapeutics Inc.

Paratek Pharmaceuticals Completes Acquisition of Optinose, Creating an Expanded Portfolio of Specialty Therapies Benzinga · 2025-05-21 · positive $HAREHOLDER ALERT: The M&A Class Action Firm Continues To Investigate The Merger – OPTN, SLRN, AKYA, SHYF GlobeNewswire Inc. · 2025-04-04 · neutral Optinose Cancels Fourth Quarter and Full Year 2024 Earnings Call GlobeNewswire Inc. · 2025-03-20 · neutral Paratek Pharmaceuticals to Acquire Optinose, Creating Significant Commercial Expansion Opportunities for XHANCE® in Chronic Rhinosinusitis (CRS) Benzinga · 2025-03-20 · positive Paratek Pharmaceuticals to Acquire Optinose, Creating Significant Commercial Expansion Opportunities for XHANCE® in Chronic Rhinosinusitis (CRS) GlobeNewswire Inc. · 2025-03-20 · positive Windtree Announces the Addition of Leanne Kelly to Its Board of Directors GlobeNewswire Inc. · 2025-01-13 · neutral

News & sentiment via Polygon.io

FAQ

Option Therapeutics Inc.: frequently asked questions

Is Option Therapeutics Inc. an American company?

Option Therapeutics Inc. is a US-based company headquartered in Carson City, Nevada, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.

Where is Option Therapeutics Inc. headquartered?

Option Therapeutics Inc. is headquartered in Carson City, Nevada, United States.

Is Option Therapeutics Inc. publicly traded?

Yes — Option Therapeutics Inc. is a publicly traded company. Its stock trades under the ticker symbol OPTN.

What does Option Therapeutics Inc. do?

Option Therapeutics Inc. is an American Pharmaceuticals company in the Health & Beauty sector.

Explore